LncRNA FALEC increases the proliferation, migration and drug resistance of cholangiocarcinoma through competitive regulation of miR-20a-5p/SHOC2 axis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

LncRNA FALEC increases the proliferation, migration and drug resistance of cholangiocarcinoma through competitive regulation of miR-20a-5p/SHOC2 axis

Published:2023-05-09 Issue:9 Volume:15 Page:3759-3770
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Du Haiming¹,Hou Senlin¹,Zhang Lichao¹,Liu Chao²,Yu Tingting¹,Zhang Wei¹

Affiliation:

1. The Biliopancreatic Endoscopic Surgery Department, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, China

2. Department of Anesthesiology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Aging

Reference38 articles.

1. Current epidemiology of cholangiocarcinoma in Western countries.;Khan;J Hepatol,2022

2. Cholangiocarcinoma: a review of the literature and future directions in therapy.;Shroff;Hepatobiliary Surg Nutr,2022

3. Long non-coding RNAs: From disease code to drug role.;Zhang;Acta Pharm Sin B,2021

4. The Advancement of Long Non-Coding RNAs in Cholangiocarcinoma Development.;Ling;J Cancer,2019

5. Long Non-Coding RNAs as Molecular Biomarkers in Cholangiocarcinoma.;Yang;Front Cell Dev Biol,2022

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between lncRNA MALAT1 and Chemo-radiotherapy Resistance of Cancer Cells: Uncovered Truths;Cell Biochemistry and Biophysics;2024-05-28

2. Updated review on analysis of long non-coding RNAs as emerging diagnostic and therapeutic targets in prostate cancers;Critical Reviews in Oncology/Hematology;2024-04

3. Non-coding RNA and Drug resistance in cholangiocarcinoma;Non-coding RNA Research;2024-03

4. Long non-coding RNA (lncRNA) PVT1 in drug resistance of cancers; focus on pathological mechanisms;Pathology - Research and Practice;2024-01

5. Research Progress on the Mechanism of Non-Coding RNA in Chemotherapy Resistance of Cholangiocarcinoma;Advances in Clinical Medicine;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3